Drug

Alkavervir

As of the edition of 20 October 2026, Alkavervir is a drug: marketed, first approved in 1982 (US); no US protection is listed.

Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.

The drug

Status
Marketed; latest approval 1982
Kind
Unknown
Brand name
Veriloid
First approved
1 January 1982 (US)
Approvals on record
2 in 1 region
Holder of the most recent approval
3M

US protection

No US protection is listed.

The FDA registers list no drug-substance patent or exclusivity that counts for this drug.

This is the US only.

Who has held its approvals

CompanyRoleYears
3MApplicant and Earlier holder